Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival

European Journal of Pharmacology
Hyun Soo KimYoung Lan Kwak

Abstract

Diabetes mellitus has been known to mitigate ischemic or pharmacologic preconditioning in ischemia-reperfusion injuries. Remifentanil is a widely used opioid in cardiac anesthesia that possesses a cardioprotective effect against ischemia-reperfusion. We evaluated whether diabetes affected remifentanil preconditioning induced cardioprotection in ischemia-reperfusion rat hearts in view of anti-apoptotic pathways of survival and Ca(2+) homeostasis. Streptozotocin-induced, diabetic rats and age-matched wild-type Sprague-Dawley rats were subjected to a left anterior descending coronary artery occlusion for 30min followed by 1h of reperfusion. Each diabetic and wild-type rat was randomly assigned to the sham, ischemia-reperfusion only, or remifentanil preconditioning group. Myocardial infarct size, activities of ERK1/2, Bcl2, Bax and cytochrome c, and gene expression influencing Ca(2+) homeostasis were assessed. Remifentanil preconditioning significantly reduced myocardial infarct size compared to ischemia-reperfusion only in wild-type rats but not in diabetic rats. Remifentanil preconditioning increased expression of ERK1/2 and anti-apoptotic protein Bcl-2 and decreased expression of pro-apoptotic proteins, Bax and cytochrome c, com...Continue Reading

References

Jan 1, 1985·Progress in Cardiovascular Diseases·F S Fein, E H Sonnenblick
Mar 1, 1981·Journal of Molecular and Cellular Cardiology·S PenpargkulJ Scheuer
Nov 1, 1983·Journal of Pharmacological Methods·G D LopaschukJ H McNeill
Oct 1, 1984·The American Journal of Cardiology·J W SmithR Serokman
Nov 1, 1995·Journal of Clinical Anesthesia·P S Glass
Feb 1, 1996·Coronary Artery Disease·S W Schaffer, M Mozaffari
Sep 1, 1996·Drugs·S S Patel, C M Spencer
Apr 1, 1997·Cardiovascular Research·G N Pierce, J C Russell
Apr 1, 1997·Cardiovascular Research·D J Paulson
Mar 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J R KerstenD C Warltier
Apr 24, 2001·Pharmacology & Therapeutics·J E Schultz, G J Gross
Aug 22, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Y ZhongM A Matlib
Sep 28, 2001·British Journal of Anaesthesia·D EbelW Schlack
Nov 6, 2001·Journal of the American College of Cardiology·S GhoshM Galiñianes
Dec 12, 2001·Journal of Molecular and Cellular Cardiology·L ZhuT H Kuo
Feb 14, 2002·The Journal of Biological Chemistry·Fuminori TsurutaYukiko Gotoh
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Katsuya TanakaJudy R Kersten
Sep 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Kin M ChoiMohammed A Matlib
Aug 23, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Yan ZhongMohammed A Matlib
Apr 28, 2004·Anesthesiology·Katsuya TanakaDavid C Warltier
Jul 28, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Ki-Chul HwangYangsoo Jang
Sep 15, 2004·Molecular and Cellular Biochemistry·Frank Christopher HowarthJaipaul Singh
May 10, 2005·Journal of Molecular and Cellular Cardiology·Loren E WoldAmy J Davidoff
Jun 1, 2005·Vascular Pharmacology·Jason N PeartGarrett J Gross
Sep 18, 2007·British Journal of Anaesthesia·C K YuM G Irwin
Jan 27, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·May Al-MaghrebiDebra I Diz

❮ Previous
Next ❯

Citations

Sep 6, 2011·Basic Research in Cardiology·Yumei YeYochai Birnbaum
Feb 24, 2012·Clinical and Experimental Pharmacology & Physiology·Sheng-Hui BiJun Ren
Oct 5, 2011·Surgery Today·Akira HasegawaTakayuki Noguchi
Mar 19, 2013·The Journal of Surgical Research·Young-Chul YooYoung-Lan Kwak
Dec 19, 2014·British Journal of Pharmacology·John P HeadrickJason N Peart
Dec 3, 2014·European Journal of Pharmacology·Ji Hae JunYoung-Lan Kwak
Sep 29, 2011·Cellular Signalling·Pitchai Balakumar, Nidhi Krishan Sharma
Feb 11, 2015·The Journal of Surgical Research·Jeon-Yu HaJune-Hong Kim
May 21, 2016·Medicinal Research Reviews·Leonid N MaslovJames M Downey
Sep 7, 2016·Journal of Diabetes Research·Amin Al-AwarCsaba Varga
Sep 23, 2016·Oxidative Medicine and Cellular Longevity·Yihan ZhangZiqing Hei
Jul 22, 2016·British Journal of Pharmacology·Louise E See HoeJason N Peart
Dec 13, 2016·International Journal of Molecular Sciences·Zheng XuYang Zheng
Dec 8, 2011·Korean journal of anesthesiology·Jin Mo KimJun Kim
Apr 9, 2015·The Korean Journal of Pain·Mohamed Amin Ghobadifar
Jul 1, 2020·Molecular and Cellular Biochemistry·Amanda LochnerRuduwaan Salie

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.